Bristol-Myers Squibb Stock News
$62.14
1.57%
NYSE, Nov 06, 04:00 pm EST.
Closed.
Index
Industry
Bristol-Myers Squibb Stock News
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #AHA--Bristol Myers Squibb Presents 56-Week Phase 3 Data in Pediatric Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy for Camzyos.
Bristol Myers Squibb stock rose Thursday despite a "mixed bag" performance that included a miss from its biggest cancer drug.
Bristol Myers Squibb raised its full-year revenue outlook due to higher third-quarter revenue.
2026 revenue forecast raised to $49.75 billion to $50.25 billion 2026 EPS forecast trimmed to $6.35 to $6.55 per share, including charge Third-quarter revenue rises 7% to $13.
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb Reports Third Quarter Financial Results for 2026.
BOTHELL, Wash. & PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #ESMO--Izalontamab Brengitecan (Iza-Bren) Doubles Median Progression-Free Survival in Patients with Previously-Treated EGFR-Mutated Non-Small Cell Lung.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
